Clinical Trial Update: Study of PIVKA-II and AFP Measurement in Surveillance Program for Early Detection of Hepatocellular Carcinoma

View source ↗

Summary

Clinical trial evaluating PIVKA-II and AFP measurements for surveillance-based early detection of hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Yonsei University | Conditions: Hepatocellular Carcinoma | Status: UNKNOWN